Eliquis
apixaban
Xarelto
rivaroxaban
Pradaxa
dabigatran
anti-platelet
clopidogrel, ticagrelor (P2Y12i), aspirin
UFH dose for VTE prophylaxis
5000 units SC q8-12hr
UFH dose for VTE treatment
80 units/kg bolus IV ; 18 units/kg/hr infusion
which anticoagulant causes hyperkalemia
UFH
Lovenox
enoxaparin (LMWH)
LMWH: prophylaxis dose for VTE
30mg SC Q12hr or 40mg SC QD (if CrCl <30 = 30mg SC QD)
LMWH: treatment of VTE, UA, NSTEMI
1 mg/kg SC Q12hr or 1.5 mg/kg SC daily (inpatient VTE treatment only) (CrCl<30 = 1 mg/kg SC QD)
LMWH: treatment for STEMI <75 yo
30 mg IV bolus + 1mg/kg SC dose (same if CrCl <30)
thrombocytopenia
unexplained >50% drop in PLTs
Savaysa
edoxaban
used off-label for HIT
fondaparinux
apixaban: non valvular AF stroke prophylaxis
5 mg PO BID
apixaban 2.5 mg PO BID if:
2 of the following: 80 yo, 60kg, SCr 1.5
apixaban: treatment of VTE
10 mg PO BID x7 days, 5 mg PO BID
Xarelto: non valvular AF (stroke prophylaxis)
take with evening meal
Xarelto: VTE treatment
15 mg PO BID x21 days, 20 mg PO QD
renal CI of fondaparinux
CrCl <30
apixaban and rivaroxaban are substrates
Pgp, 3A4
Pradaxa
dabigatran
don’t put this in NG tube
dabigatran
lower doses of warfarin in (6)
elderly, malnourished, taking drugs that inc warfarin levels, liver disease, heart disease, inc risk of bleeding